Europe In-vitro Diagnostics (IVD) Market – Focused Insights 2024-2029

Europe in-vitro diagnostics (IVDs) market was valued at USD 27.75 billion in 2023 and is expected to reach USD 31.68 billion by 2029, growing at a CAGR of 2.23% during the forecast period. The market's growth is driven by increasing demand for in-vitro diagnostics solutions and an increase in the aging population with chronic infectious diseases. In addition, the increasing access to disease diagnosis and technology advancements in IVD solutions accelerate the adoption of IVD solutions.

The study considers a detailed scenario of the present in-vitro diagnostics market and its market dynamics for 2024−2029 in Europe. It thoroughly overviews several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent players operating in the market.

MARKET DEFINITION

In vitro diagnostics (IVDs) detect diseases, conditions, and infections in human blood or tissue samples. IVD medical devices include reagents, kits, instruments, equipment, or systems used to diagnose various diseases and health conditions or determine a patient's state of health.

MARKET DRIVERS

Growing Importance for Personalised Medicine: Personalised medicine is becoming increasingly important as scientists learn more about genetic makeup. The undeniable potential of digitization in healthcare is driven by this industry's capacity to recognize the worldwide demand for more advanced and personalized care. The new European Partnership for Personalised Medicine (EP PerMed) was officially launched in 2023. This will promote all areas and disciplines of precision medicine, facilitate innovation and transfer, and encourage its consolidation in health systems, allowing continuous improvement.

Increasing Adoption of Automation in Laboratories: Integrating automation into the IVD manufacturing process benefits IVD device designers and manufacturers. Automation allows for the inclusion of software-based calculation, calibration, and documentation, improving test efficiency, calibration schedules, regulatory compliance, and instrument/equipment traceability. These benefits lead to less labor, reduced errors (standardization) risk, and fewer calibration tests. Furthermore, automated volumetric measurements simplify production fabrication processes by giving manufacturers better control over manufacturing equipment and steps on the production line. 

EUROPE IN-VITRO DIAGNOSTICS (IVDs) MARKET INSIGHTS

• The reagents and consumables segment occupies a major market share of over 65% in the Europe in-vitro diagnostics (IVDs) market, owing to increasing focus on research in molecular biology and technological advancements in genomic sequencing. With the increasing adoption of in-vitro diagnostics solutions, the demand for reagents and consumables is increasing. Infectious diseases and pandemics such as COVID-19 significantly fuel the demand for reagents in diagnosis.
• The hematology technology segment is growing significantly, with the fastest-growing CAGR during the forecast period. The growth of the hematology market is attributed to the increasing incidences of blood disorders and other diseases, rapid technological advances in hematology, and the emergence of high throughput hematology analyzers. As the demand for testing has surged in recent years, the laboratory's role in diagnosing and managing diseases has grown significantly.
• The diabetic application segment showcases the highest growth rate in the Europe in-vitro diagnostics (IVDs) market. Rising health consciousness among the population and the demand for diabetes monitoring devices, coupled with the easy availability of advanced diabetes devices, are fostering market growth in this segment.
• By end-user, the standard reference labs segment dominated the market share of the Europe in-vitro diagnostics (IVDs) market. In recent years, standard reference laboratories have rapidly expanded to offer numerous tests and deliver high market growth by adopting new technologies and product offerings, thus driving market growth.

REGIONAL ANALYSIS

Spain shows the highest growth rate, with a CAGR of 3% in Europe's in-vitro diagnostics (IVDs) market. The demand for IVD solutions has increased in the country due to the rising prevalence of chronic diseases associated with the aging population. In addition, awareness of early detection and diagnosis of various diseases, point-of-care IVD solutions, and advancing technologies in healthcare settings are major factors contributing to market growth.

VENDOR LANDSCAPE

The Europe in-vitro diagnostics (IVDs) market report contains exclusive data on 89 vendors. The competition among market players in the IVD market is significantly high for products, solutions, reagents, consumables, and services in terms of pricing, product, and associated brand image, services, and associated quality, a new product launched and developed, customer services, and financing terms. The leading market players in the Europe IVD market are Abbott Laboratories, bioMerieux, Danaher, Hoffmann-La Roche, Bio-Rad Laboratories, Siemens Healthineers, Thermo Fisher Scientific, and Diasorin, which are competing with rapidly emerging market players. Vendors in the market are increasing their market share through inorganic growth.